Long‐Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
Journal of the American Heart Association · 16.07.2024 · 13 (14)
DOI: 10.1161/jaha.123.033485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 16.07.2024. Verfasst von Jeffrey R Boris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey R. Boris, MD LLC Moylan PA USA. Hauptthemen laut MEDLINE: Quality of Life, Postural Orthostatic Tachycardia Syndrome. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Limited data exist on long‐term outcomes in individuals with postural orthostatic tachycardia syndrome (POTS). We designed an electronic questionnaire assessing various aspects of outcomes among patients diagnosed and treated in a single‐center pediatric POTS clinical program. Methods and Results The LT‐POTS (Long Term POTS Outcomes Survey) included questions about quality of life, symptoms, therapies, education, employment, and social impact of disease. Patients age≤18 years at POTS diagnosis who were managed in the Children's Hospital of Philadelphia POTS Program were included. A total of 227 patients with POTS responded with sufficient data for interpretation. The mean age of respondents was 21.8±3.5 years. The median age of symptom onset was 13 (interquartile range 11–14) years, with mean 9.6±3.4 years symptom duration. Multiple cardiovascular, neurologic, and gastrointestinal symptoms were reported. Symptom prevalence and severity were worse for female patients, with 99% of patients reporting ongoing symptoms. Quality of life showed moderate function and limitation, with more severe limitations in energy/fatigue and general health. Nearly three quarters of patients had diagnostic delays, and over half were told that their symptoms were “in their head.” Multiple medications were used and were felt to be effective, whereas fewer nonpharmacologic interventions demonstrated efficacy. Nearly 90% of patients required continued nonpharmacologic therapy to control symptoms.
Conclusions
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. Although symptoms can be modifiable, it rarely spontaneously resolves. Improved understanding of POTS presentation and therapeutic approaches may inform provider education, improve diagnostic success, and help patients self‐advocate for appropriate medical management approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jeffrey R. Boris, MD LLC Moylan PA USA.
- War Related Illness and Injury Study Center, VA New Jersey Healthcare System East Orange NJ USA.
- Mitochondrial Medicine Frontier Program Children's Hospital of Philadelphia Philadelphia PA USA.
- Department of Pediatrics, Perelman School of Medicine University of Pennsylvania Philadelphia PA USA.
ORCID-Profile: Jeffrey R Boris, Edward C Shadiack, Laura MacMullen, Ibrahim George-Sankoh, Marni J Falk
Zitieren
APA
Boris, J. R., Shadiack, E. C., McCormick, E. M., MacMullen, L., George-Sankoh, I., & Falk, M. J. (2024). Long‐Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes. Journal of the American Heart Association, 13(14). https://doi.org/10.1161/jaha.123.033485
Vancouver
Boris JR, Shadiack EC, McCormick EM, MacMullen L, George-Sankoh I, Falk MJ. Long‐Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes. Journal of the American Heart Association. 2024;13(14). doi:10.1161/jaha.123.033485
BibTeX
@article{Boris2024,
author = {Boris, Jeffrey R and Shadiack, Edward C and McCormick, Elizabeth M and MacMullen, Laura and George-Sankoh, Ibrahim and Falk, Marni J},
title = {Long‐Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {14},
doi = {10.1161/jaha.123.033485}
}
EUVIMED